Navigation Links
United States Oncology Drug Delivery Preferences and Opportunities in Cancer Drug Delivery
Date:11/19/2012

NEW YORK, Nov. 19, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

United States Oncology Drug Delivery Preferences and Opportunities in Cancer Drug Delivery  
http://www.reportlinker.com/p01042201/United-States-Oncology-Drug-Delivery-Preferences-and-Opportunities-in-Cancer-Drug-Delivery .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology Research Objectives

•Understand trends, dynamics, and parameters specific to the delivery of drugs to cancer patients in key treatment settings such as home, office, or infusion center.
•Identify physician prescribing trends relative to drug delivery considerations.
•Understanding the role of reimbursement in physician's choice of drug delivery.
•Identify physicians' perception of different drug delivery approaches, as well as key drivers for adoption/non-adoption, compliance, and choice of delivery devices.
•Identify drug delivery trends within the oncology area.
•Determine product attributes relative to delivery that are considered to be important by physicians and patients.
•Identify prospective patient preferences and willingness to try new technologies as well as determine key drivers of adoption/non-adoption.

Industry Background

Drug delivery is an important area of drug development in the pharmaceutical and biotechnology industry. In oncology, developers are interested in understanding the opportunities and parameters for deliv
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
2. Student of Liver And Vascular Surgery of West China Hospital of Sichuan University Addresses The 18th ILTS Annual Meeting in the United States
3. Eleven Integrated Health Systems Form Largest Private-Sector Diabetes Registry in United States
4. United Spinal To "Roll on Capitol Hill:" Voices Aim to Impact Federal Health Care Policy
5. United States ENT Devices Market Outlook to 2018 - Diagnostic Devices, Hearing Aid Devices, Hearing Implants and Others
6. Zimmer Introduces First Porous Metal Interbody Implant for Lumbar Spine in the United States
7. United Kingdom ENT Devices Market Outlook to 2018 - Diagnostic Devices, Hearing Aid Devices, Hearing Implants and Others
8. United States Surgical Equipment Market Outlook to 2018- Electrosurgical Devices, Hand Instruments and Surgical Sutures
9. United States Market for Psoriatic Arthritis Pharmacotherapy
10. 2012 United States Medical Devices Outlook
11. Celladon Corporation Receives Patent from United States Patent and Trademark Office
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... -- Uroplasty, Inc. (NASDAQ: UPI ), a medical ... proprietary products to treat voiding dysfunctions, will host ... March 12, 2015, beginning at 3:00 pm Central ... Minnetonka , Minnesota.     Rob ... host the meeting, which will feature a discussion ...
(Date:3/3/2015)... March 3, 2015 Although lung cancer is ... there are only 18 drugs in the market for ... Avastin are nearing their patent expiry in 2015 and ... offers vast potential that drug manufacturers are vying to ... small cell lung cancer (SCLC) and non-small cell lung ...
(Date:3/3/2015)... March 3, 2015 ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") ... , Chief Executive Officer of ImmunoCellular, will present a ... Annual ROTH Conference on Tuesday, March 10, 2014 ... Laguna Niguel , CA.   ... presentation, please log on through a link located in ...
Breaking Medicine Technology:Uroplasty to Host Investor Meeting at Corporate Headquarters 2Uroplasty to Host Investor Meeting at Corporate Headquarters 3Uroplasty to Host Investor Meeting at Corporate Headquarters 4Uroplasty to Host Investor Meeting at Corporate Headquarters 5Uroplasty to Host Investor Meeting at Corporate Headquarters 6Targeted Lung Cancer Therapies Are Supplanting Conventional Treatments 2Targeted Lung Cancer Therapies Are Supplanting Conventional Treatments 3ImmunoCellular Therapeutics to Present at ROTH Conference on March 10th 2
... , CAMBRIDGE, Mass., Nov. 19 Ligon Discovery, Inc., ... drugs against high-value targets, today announced that it has ... The company will use the capital to complete its ... disease protein targets. With this investment, incTANK Ventures General ...
... , NEWPORT NEWS, Va., Nov. 19 Breast-Specific Gamma ... by two highly esteemed organizations for the fight against ... the American College of Surgeons. Both societies published articles ... for the early detection of breast cancer. , "These ...
Cached Medicine Technology:Cambridge-based Ligon Discovery Raises $1M in Seed Funding 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 3Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 2Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 3
(Date:3/3/2015)... 03, 2015 Celestix Networks, the ... today announced the global availability of Celestix Cloud ... the world’s most deployed platform for DirectAccess and ... R2. This new release enables organizations to manage ... from a single HTML 5 web interface called ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 Jack Coats, ... that Mr. William A. Breukelman has been named to ... completed development of the first fully integrated version of ... capable of analyzing the three-dimensional motion of the heart ... comparing the analysis at 15,300 points to the motion ...
(Date:3/3/2015)... 03, 2015 Using an “intelligent,” rather ... Medicare Part D prescription drug coverage plans could save ... new University of Pittsburgh Graduate School of Public Health ... the March issue of the journal Health Affairs and ... have saved more than $5 billion in its Part ...
(Date:3/3/2015)... Miami, FL (PRWEB) March 03, 2015 ... to be an international keynote presenter at the ... at the Melbourne Convention and Exhibition Centre March ... on Wednesday, March 11, at 11 am (Melbourne ... Emotions and Interests,” will discuss making each customer’s ...
(Date:3/3/2015)... A recent study of the correlation ... and radio host Sharon Kleyne has been saying for ... water in the body – is extremely widespread ... the US population. Kleyne further believes that research will ... all disease, including aging and stroke. , ...
Breaking Medicine News(10 mins):Health News:Introducing Celestix Cloud Edge Security 2.0 for Increased Security in DirectAccess Client Management 2Health News:Introducing Celestix Cloud Edge Security 2.0 for Increased Security in DirectAccess Client Management 3Health News:William A. (Bill) Breukelman Named to CardioWise, Inc. Board of Directors 2Health News:William A. (Bill) Breukelman Named to CardioWise, Inc. Board of Directors 3Health News:Medicare and Patients with Schizophrenia Could Save $150 Million on Part D Plans 2Health News:Medicare and Patients with Schizophrenia Could Save $150 Million on Part D Plans 3Health News:South Florida-based PureFormulas will discuss personalization at ecommerce Conference and Expo in Melbourne, Australia 2Health News:Study linking dehydration and stroke severity supports fresh water advocate’s warnings 2Health News:Study linking dehydration and stroke severity supports fresh water advocate’s warnings 3
... HealthDay Reporter , THURSDAY, Aug. 25 (HealthDay News) -- For kids, ... late and sleeping until noon: It also signals the beginning of ... Whether your child is a preschooler or a teen, some ... for parents is to know how to ease your children,s stress ...
... HealthDay Reporter , THURSDAY, Aug. 25 (HealthDay News) -- An ... finds that children,s vaccines are typically safe, with bad reactions ... problems. The IOM committee also agreed that there is ... later onset of conditions such as autism or type 1 ...
... the basis of new and effective treatments for ovarian ... and Portsmouth. The scientists are developing ... to stop cells from ovarian tumours growing. In initial ... from cancer patients. The extracts are complex mixtures ...
... 2011 -- Heart rate and blood pressure regulation may hold ... a new study by researchers at Wake Forest Baptist Medical ... as orthostatic intolerance (OI), which causes dizziness and occasional fainting ... debilitating chronic nausea in patients., "There seems to be a ...
... diagnostic imaging technique, physicians now have an objective test ... disease. Northwestern Memorial Hospital is among the first institutions ... imaging agent for assessment of movement disorders. Until now, ... forcing physicians to rely on clinical examinations to make ...
... An analysis of more than 1,000 research articles ... clearly associated with vaccines. A committee of experts ... scientific literature on possible adverse effects of vaccines found ... inflammation of the brain, and fainting -- that can ...
Cached Medicine News:Health News:Parents Can Ease Back-to-School Stress 2Health News:Parents Can Ease Back-to-School Stress 3Health News:U.S.-Mandated Report Finds Vaccines Safe for Kids 2Health News:U.S.-Mandated Report Finds Vaccines Safe for Kids 3Health News:U.S.-Mandated Report Finds Vaccines Safe for Kids 4Health News:Plants could pave the way for new ovarian cancer treatments 2Health News:Heart may hold key to unexplained nausea in youths 2Health News:New imaging test gives physicians better tool to diagnose Parkinson's disease 2Health News:New imaging test gives physicians better tool to diagnose Parkinson's disease 3Health News:Few health problems are caused by vaccines, IOM report finds 2Health News:Few health problems are caused by vaccines, IOM report finds 3
... glucuronide (3alpha-diol G) is the glucuronide ... of dihydrotestosterone (DHT) [1,2]. 3alpha-diol G ... 75% of the bioactivity of testosterone ... product of intracellular reduction of DHT, ...
... Activins are polypeptide hormones which ... (TGF-) superfamily. The TGF- superfamily is ... factors which control many aspects of ... (1). Other members incude TGF-s, bone ...
... Gla protein, is a vitamin K-dependent, calcium ... of the noncollagenous bone matrix [1,2,3]. Osteocalcin ... a small amount produced by odontoblasts in ... formation, newly synthesized osteocalcin is incorporated into ...
... binding protein-2 (IGFBP-2) is one of six ... which specifically bind and modulate the actions ... of IGFBP-2 for IGF-II is estimated to ... suggesting a role in regulation of IGF-II ...
Medicine Products: